DexCom, Inc. DXCM

86.62 (0.85) (0.97%) as of 25 Sep
Market cap
$33.0B
P/E
33.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

DexCom, Inc. (DXCM) Operating margin

DexCom, Inc.'s operating margin over the twelve months to 30 June 2026 was 22.9%, up 3.4 percentage points from fiscal 2025 (19.6%). Over the past ten years it has ranged from −18.1% (fiscal 2018) to 19.6% (fiscal 2025) — the current reading is the highest in ten years. That is above the Medical Devices industry median of −15.0% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Annual

Period Operating margin Change (points)
FY2025 19.6% 4.68
FY2024 14.9% (1.62)
FY2023 16.5% 3.06
FY2022 13.4% 2.58
FY2021 10.9% (4.68)
FY2020 15.5% 5.90
FY2019 9.64% 27.70
FY2018 −18.1% (12.14)
FY2017 −5.92% 5.23
FY2016 −11.2% 3.05

Quarterly

Period Operating margin Change (points)
Jun 2026 24.3% 2.91
Mar 2026 21.4% (4.22)
Dec 2025 25.6% 5.59
Sep 2025 20.1% 1.68
42 more quarters

Against its own ten years

Low −18.1% High 19.6%
Ten-year median 10.9%
Current reading's percentile 100

Operating margin against peers

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on DXCM